This invention relates to benzoxazine and benzoxazinone substituted triazoles which are inhibitors of the transforming growth factor, (“TGF”)-β signalling pathway, in particular, the phosphorylation of smad2 or smad3 by the TGF-β, type I or activin-like kinase (“ALK”)-5 receptor, methods for their preparation and their use in medicine, specifically in the treatment and prevention of a disease state mediated by this pathway.
本发明涉及
苯并噁嗪和
苯并噁嗪
酮取代的三
唑类化合物,它们是转化生长因子("TGF")-β 信号通路的
抑制剂,特别是 TGF-β、I 型或类活化因子激酶("ALK")-5 受体对 smad2 或 smad3
磷酸化的
抑制剂,本发明还涉及它们的制备方法及其在医学中的用途,特别是在治疗和预防由该通路介导的疾病中的用途。